8. Observational French CA. NUT Study of the molecular . 2010 study Midline Carcinoma. cytogenetics of NUT Cancer genetics midline carcinoma and cytogenetics. (NMC) demonstrating 2010;203(1):16-20. the presence of abnormality t(15;19)(q14;p13.1), BRD4-NUT fusion, and NUT-variants where the partner genes is BRD3 or other uncharacterised genes. The study indicated that the histological features of NMC are not diagnostic and the commonly undiagnosed or misdiagnosed and that the true frequency of NMC is yet to be determined. 9. Observational Rare Cancers A review of available 2016 study Australia: Just a cancer data Little More Time investigating the Rare Cancers disparities existing for Update Report. incidence, mortality 2016 and survival across the cancer spectrum. The study provided a definition for rare cancers, and the burden of disease that rare and less common cancers pose across all ages in Australia 10. Chau NG, Hurwitz A retrospective review 2016 S, Mitchell CM, et of all known cases of al. Intensive HNNMC in the treatment and International NUT survival outcomes Midline Carcinoma in NUT midline Registry as of carcinoma of the December 31, 2014, head and neck. was performed. 48 Cancer. consecutive patients were treated from 1993 to 2014, and clinicopathologic variables and outcomes for 40
8. Observational study French CA. NUT Midline Carcinoma. Cancer genetics and cytogenetics. 2010;203(1):16-20. Study of the molecular cytogenetics of NUT midline carcinoma (NMC) demonstrating the presence of abnormality t(15;19)(q14;p13.1), BRD4-NUT fusion, and NUT-variants where the partner genes is BRD3 or other uncharacterised genes. The study indicated that the histological features of NMC are not diagnostic and the commonly undiagnosed or misdiagnosed and that the true frequency of NMC is yet to be determined. . 2010 9. Observational study Rare Cancers Australia: Just a Little More Time Rare Cancers Update Report. 2016 A review of available cancer data investigating the disparities existing for incidence, mortality and survival across the cancer spectrum. The study provided a definition for rare cancers, and the burden of disease that rare and less common cancers pose across all ages in Australia 2016 10. Chau NG, Hurwitz S, Mitchell CM, et al. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck. Cancer. A retrospective review of all known cases of HNNMC in the International NUT Midline Carcinoma Registry as of December 31, 2014, was performed. 48 consecutive patients were treated from 1993 to 2014, and clinicopathologic variables and outcomes for 40 2016